Search results for: Innovation Policy Prize
Filter search results
Patrick Holmes
3 February 2023
…is the Science and Innovation Policy Lead at Pfizer based in New York and heads a team responsible for developing global health policy initiatives and evidence across a series of…
From STEDI to STRIDES: Valuing broader health-system benefits of AMR diagnostics
21 July 2025
…AMR. This under-recognition hinders effective policy making, discourages innovation and perpetuates structural and financial disincentives. In our latest report on AMR diagnostics, we identify key barriers to uptake and roll-out: …
Professor Dr Hasan Hüseyin Yildirim
26 January 2024
…reforms and innovation initiatives in Türkiye. He is a member of the G20 Global Innovation Hub for Improving Value in Health Steering Committee. Hasan previously served as the Founding Director…
Research Funding and Economic Growth
9 December 2011
…done and communities develop. There is an important distinction to make between economic ‘multipliers’ and ‘spillovers’ that needs to influence how policymakers approach the issue. Multipliers occur when, for example,…
Orphan Drugs Policies: A Suitable Case for Treatment
20 May 2014
…be clarified as the basis for policy revisions. The editorial is intended ‘not to provide complete solutions to all the policy problems, but rather to set out a roadmap whereby they…
Spotlight on OHE: Assessing Value and Balancing Needs in Health Care
15 December 2011
…options for, value based pricing in the UK at the NextLevel Pharma conference and in a parallel session at NHS North West’s Health Innovation and Education Clusters conference. Martina Garau…
Benefiting Sooner from Medical Research
3 February 2015
…policy and practice. Health Research Policy and Systems, 13(1), pp.1-18. We reviewed academic and policy literatures; and most importantly we undertook detailed case studies of the research histories of…
NICE Recommendation Highlights Role of Social Value Judgements
9 August 2018
…to selecting and attaching weights to different decision criteria. It is worth noting that NICE’s policy on the appraisal of life-extending end of life treatments – the only policy which…
Rosanna Tarricone
8 June 2025
…focuses on health technology assessment (HTA), health policy, and the economic evaluation of health technologies, with particular interest in sustainability, access, and innovation in healthcare systems. She has contributed to…